Drugs News and Research

RSS

Biosimilars offer access to both established and new treatment options for inflammatory diseases

Drugs produced using biotechnology are among the most expensive medicines available. Biosimilars that offer a real alternative are becoming increasingly available on the market.

20 Oct 2015

Leading obesity groups stress need to regulate weight-loss dietary supplements

On the heels of a new study tying dietary supplements to more than 23,000 emergency room visits each year, four leading obesity research, treatment and prevention groups issue a joint scientific statement recommending dietary supplements for weight loss claiming curative or medicinal qualities be subject to review and approval by the United States Food and Drug Administration (FDA).

20 Oct 2015

Research: Heavy drinkers, illegal drug users downplay their consumption levels compared to others

Heavy drinkers and users of illegal drugs downplay their relative levels of consumption, when comparing themselves to others, reveals research by the London School of Economics and Political Science and South London and Maudsley NHS Foundation Trust.

20 Oct 2015

Consuming high-fat diet may lead to anxiety and depression, cause measurable changes in the brain

A new study in mice reveals that increased body weight and high blood sugar as a result of consuming a high-fat diet may cause anxiety and depressive symptoms and measurable changes in the brain.

20 Oct 2015

First patients receive doses of antisense drug for Huntington's disease

The first few patients have received doses of an experimental RNA-targeting drug for Huntington's disease, it was announced today.

20 Oct 2015

Research finding points towards developing effective malaria vaccine

In a recent breakthrough to combat malaria, a collaboration of Indian and American scientists have identified a malarial parasite protein that can be used to develop antibodies when displayed on novel nanoparticles. This approach has the potential to prevent the parasite from multiplying in the human host and also inhibits transmission through mosquitoes. The finding points towards developing a powerful malaria vaccine in the hope of eradicating this debilitating and often fatal disease.

20 Oct 2015

New report finds tremendous opportunities for TB diagnostics in Brazil, China, India and South Africa

Brazil, China, India and South Africa, which together account for nearly half of all new tuberculosis (TB) cases, offer “tremendous opportunities” for new diagnostics due to their commitment to fight the disease at a time when investments in new technologies are on the increase, according to a new report from FIND, McGill International TB Centre, and UNITAID.

20 Oct 2015

Sigma-Aldrich, Sanger Institute partner to manufacture and distribute arrayed lentiviral CRISPR library

Sigma-Aldrich Corporation today announced it has entered into an exclusive agreement with the Wellcome Trust Sanger Institute to manufacture and distribute the Sanger Institute's arrayed lentiviral CRISPR library. The library will be the first of its kind, providing researchers with a collection of individual clones designed to knock out every known human and mouse protein-coding gene using the CRISPR system.

20 Oct 2015

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year. Diabetic retinopathy is the most common complication of diabetes.

19 Oct 2015

Biophor receives FDA 510(k) clearance for distribution of seventh oral fluid screening assay

Biophor Diagnostics, Inc. announces that it has received FDA 510(k) clearance for sale and distribution of its seventh oral fluid screening assay based on the RapidFRET IVD Platform technology. This clearance completes the company's flagship panel for drugs of abuse screening in oral fluid.

19 Oct 2015

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

LEO Pharma Inc., a wholly owned U.S. subsidiary of LEO Pharma A/S, announced today that Enstilar has been approved by the U.S. Food and Drug Administration for the topical treatment of plaque psoriasis in adults 18 years of age and older.

19 Oct 2015

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

Sprout Pharmaceuticals, Inc., a division of Valeant Pharmaceuticals North America LLC, announced today that Addyi, a once-daily, non-hormonal pill for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, is now available in the United States through certified physicians and pharmacies.

19 Oct 2015

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced that yesterday it presented positive preclinical data demonstrating the promising potential of its lead product candidate VAL-083 (dianhydrogalactitol) as a treatment for ovarian cancer.

19 Oct 2015

TARSA Therapeutics' TBRIA NDA accepted by FDA for review

TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.

19 Oct 2015

Outreach program increases completion of HPV vaccination series by teens in safety-net settings

A joint study by UT Southwestern Medical Center and Parkland Health & Hospital System investigators found that a multicomponent outreach program increased completion of the three-dose human papillomavirus (HPV) vaccination series that reduces the risk of cervical cancer caused by the virus.

19 Oct 2015

NCCN reveals new value initiative for CML and Multiple Myeloma

The National Comprehensive Cancer Network, a not-for-profit alliance of 26 of the world's leading cancer centers, today unveiled its new value initiative—the NCCN Evidence Blocks, published within new versions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Chronic Myelogenous Leukemia (CML) and Multiple Myeloma.

19 Oct 2015

Rutgers School of Nursing takes lead in $6 million nationwide effort to prevent new HIV infections

Rutgers School of Nursing is taking the lead in a $6 million nationwide effort to greatly reduce new HIV infections - a battle complicated by both the aging of career HIV health care professionals and a failure to engage all people living with HIV into treatment.

19 Oct 2015

Drugs News and Research

Biosimilars offer access to both established and new treatment options for inflammatory diseases

Leading obesity groups stress need to regulate weight-loss dietary supplements

Research: Heavy drinkers, illegal drug users downplay their consumption levels compared to others

Consuming high-fat diet may lead to anxiety and depression, cause measurable changes in the brain

First patients receive doses of antisense drug for Huntington's disease

Research finding points towards developing effective malaria vaccine

New report finds tremendous opportunities for TB diagnostics in Brazil, China, India and South Africa

Sigma-Aldrich, Sanger Institute partner to manufacture and distribute arrayed lentiviral CRISPR library

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

Biophor receives FDA 510(k) clearance for distribution of seventh oral fluid screening assay

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

TARSA Therapeutics' TBRIA NDA accepted by FDA for review

Outreach program increases completion of HPV vaccination series by teens in safety-net settings

NCCN reveals new value initiative for CML and Multiple Myeloma

Rutgers School of Nursing takes lead in $6 million nationwide effort to prevent new HIV infections

UCSF scientists urge hospitals to buy only antibiotic-free meat to help stop spread of antibiotic resistance

TGen researchers join international scientists in discovering how malaria protein could some day help stop cancer

BWH, HSCI establish new method for making kidney structures from stem cells derived from patients

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News